- Home
- SUNC vs ITGR Comparison
SUNC vs ITGR Comparison
Compare SUNC & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUNC | ITGR |
|---|---|---|
| Founded | 2000 | 1970 |
| Country | United States | United States |
| Employees | 8910 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | SUNC | ITGR |
|---|---|---|
| Price | $66.33 | $92.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $61.00 | ★ $91.14 |
| AVG Volume (30 Days) | 459.5K | ★ 489.5K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $65.29 | $1.69 |
| Revenue Next Year | $0.84 | $6.53 |
| P/E Ratio | ★ N/A | $193.21 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $47.00 | $62.00 |
| 52 Week High | $73.24 | $123.78 |
Technical Indicators
Market Signals| Indicator | SUNC | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 59.88 |
| Support Level | $64.70 | $82.58 |
| Resistance Level | $73.24 | $106.08 |
| Average True Range (ATR) | 1.54 | 2.30 |
| MACD | -0.58 | 0.19 |
| Stochastic Oscillator | 15.97 | 67.14 |
Price Performance
Historical ComparisonAbout SUNC SunocoCorp LLC
SunocoCorp LLC is a publicly traded limited liability company that owns a direct limited partner interest in Sunoco LP. It engages in the management and distribution of fuel products. It operates through the following segments: Fuel Distribution, Pipeline Systems, and Terminals and Refinery.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.